Interacting Drugs |
Bacitracin, neomycin, polymyxin B, and hydrocortisone vs Acarbose |
Security Level |
 |
Mechanism |
Acarbose: Neomycin may enhance the adverse/toxic effect of Acarbose. Neomycin may enhance the therapeutic effect of Acarbose. Neomycin may decrease the metabolism of Acarbose. |
Management |
Monitor therapy |
Bacitracin, neomycin, polymyxin B, and hydrocortisone vs Acarbose
Post Review about Bacitracin, neomycin, polymyxin B, and hydrocortisone vs Acarbose Click here to cancel reply.
Other Interactions of Bacitracin, neomycin, polymyxin B, and hydrocortisone
Other Interactions of Acarbose
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.